2,2,5,7,8-pentamethyl-1-hydroxychroman and Colorectal Cancer

2,2,5,7,8-pentamethyl-1-hydroxychroman has been researched along with Colorectal Cancer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Coppola, D; Husain, K; Malafa, MP; Yang, CS	1

Other Studies

1 other study(ies) available for 2,2,5,7,8-pentamethyl-1-hydroxychroman and Colorectal Cancer

Article	Year
Farnesyl dimethyl chromanol targets colon cancer stem cells and prevents colorectal cancer metastasis. Scientific reports, 2021, 01-26, Volume: 11, Issue:1 Topics: 3T3 Cells; Animals; Apoptosis; beta Catenin; Biomarkers, Tumor; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Shape; Chromans; Colorectal Neoplasms; Female; Inflammation; Mice; Mice, Nude; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplastic Stem Cells; Neovascularization, Pathologic; Organoids; Spheroids, Cellular; Transcription Factors; Wnt Signaling Pathway	2021

Article

Year

Farnesyl dimethyl chromanol targets colon cancer stem cells and prevents colorectal cancer metastasis.

Scientific reports, 2021, 01-26, Volume: 11, Issue:1

Topics: 3T3 Cells; Animals; Apoptosis; beta Catenin; Biomarkers, Tumor; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Shape; Chromans; Colorectal Neoplasms; Female; Inflammation; Mice; Mice, Nude; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplastic Stem Cells; Neovascularization, Pathologic; Organoids; Spheroids, Cellular; Transcription Factors; Wnt Signaling Pathway

2021